Karriereverlauf von Al Boyle
Ehemalige bekannte Positionen von Al Boyle
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2015 | 01.04.2023 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.08.2009 | 01.11.2015 |
Ausbildung von Al Boyle
| SUNY College of Environmental Science | Graduate Degree |
| Rutgers State University of New Jersey | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Frankreich | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
